Muscarinic agonists as cognitive enhancers

Methods of treating a mental condition by administering to a subject in need thereof an effective amount of compound CDD-102A, [5-(3-ethyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine] are described.
Download pdf
Abstract/Description: Methods of treating a mental condition by administering to a subject in need thereof an effective amount of compound CDD-102A, [5-(3-ethyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine] are described.
Subject(s): A61K31/506
Date Issued: 2020-11-17
Title: Muscarinic agonists as cognitive enhancers.
Name(s): Messer Jr., William S., inventor
Ragozzino, Michael E., inventor
The University of Toledo, assignee
The Board of Trustees of the University of Illinois, assignee
Type of Resource: text
Genre: patent
Date Issued: 2020-11-17
Other Date: Date Filed: 2013-10-17
Publisher: United States Patent and Trademark Office
Physical Form: application/pdf
Extent: 21 p.
Abstract/Description: Methods of treating a mental condition by administering to a subject in need thereof an effective amount of compound CDD-102A, [5-(3-ethyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine] are described.
Identifier(s): utpatents-US10835532 (IID)
Patent No.: US10835532 (patno)
Appl. No.: 14/056616 (appno)
Subject(s): A61K31/506
Held by: United States Patent and Trademark Office (USPTO) Public Search Facility
Location: University of Toledo Digital Repository
Rights Statement: No Copyright - United States
In Collections: